TECHWIRE 30
(CIX: WRAL30)  1,110.36    (0 %)  Updated: 08:10 PM EDT, Aug 29 2014
(NQ: Apple)  102.50    (0 %)  Updated: 08:10 PM EDT, Aug 29 2014
(NY: QUINTILES)  56.12    (0 %)  Updated: 06:40 PM EDT, Aug 29 2014
(OP: BASF SE)  102.90    (0 %)  Updated: 08:10 PM EDT, Aug 29 2014
(NQ: BioCryst)  13.50    (0 %)  Updated: 08:10 PM EDT, Aug 29 2014
(NQ: BioDelivery)  16.00    (0 %)  Updated: 08:10 PM EDT, Aug 29 2014
(NQ: CEMP)  10.57    (0 %)  Updated: 08:10 PM EDT, Aug 29 2014
(NQ: Cisco Systems)  24.99    (0 %)  Updated: 08:10 PM EDT, Aug 29 2014
(NQ: Cree)  45.56    (0 %)  Updated: 08:10 PM EDT, Aug 29 2014
(NQ: DARA)  1.25    (0 %)  Updated: 08:10 PM EDT, Aug 29 2014
(NY: EMC CORPORATION)  29.53    (0 %)  Updated: 06:40 PM EDT, Aug 29 2014
(NQ: Extreme Networks)  5.33    (0 %)  Updated: 08:10 PM EDT, Aug 29 2014
(NQ: FB)  74.82    (0 %)  Updated: 08:10 PM EDT, Aug 29 2014
(NY: GLAXOSMITHKLINE)  49.10    (0 %)  Updated: 06:40 PM EDT, Aug 29 2014
(NQ: GOOG)  571.60    (0 %)  Updated: 08:10 PM EDT, Aug 29 2014
(NY: IBM)  192.30    (0 %)  Updated: 06:40 PM EDT, Aug 29 2014
(NY: LH)  107.23    (0 %)  Updated: 06:40 PM EDT, Aug 29 2014
(OP: Lenovo Group)  30.52    (0 %)  Updated: 08:10 PM EDT, Aug 29 2014
(NY: MRK)  60.11    (0 %)  Updated: 06:40 PM EDT, Aug 29 2014
(NQ: Microsoft Corp)  45.43    (0 %)  Updated: 08:10 PM EDT, Aug 29 2014
(NQ: NTAP)  42.16    (0 %)  Updated: 08:10 PM EDT, Aug 29 2014
(NY: NOVARTIS AG)  89.84    (0 %)  Updated: 06:40 PM EDT, Aug 29 2014
(OP: Novozymes A/S)  46.24    (0 %)  Updated: 08:10 PM EDT, Aug 29 2014
(NY: PFIZER)  29.39    (0 %)  Updated: 06:40 PM EDT, Aug 29 2014
(NQ: Pozen)  8.30    (0 %)  Updated: 08:10 PM EDT, Aug 29 2014
(NY: RED HAT)  60.92    (0 %)  Updated: 06:40 PM EDT, Aug 29 2014
(NQ: BBRY)  10.18    (0 %)  Updated: 08:10 PM EDT, Aug 29 2014
(NQ: Salix)  159.11    (0 %)  Updated: 08:10 PM EDT, Aug 29 2014
(NQ: SQI)  15.97    (0 %)  Updated: 08:10 PM EDT, Aug 29 2014

Posts tagged “Merck”

July 22, 2009

Premium Lock Wyeth plant in Sanford closer to new ownership by Pfizer

Pfizer Shareholders of drugmaker Wyeth on Monday voted overwhelmingly to be bought by industry giant Pfizer Inc., pushing aside one of the deal's final hurdles.

Updated July 9, 2009

Premium Lock World Health Organization approves GSK cervical cancer vaccine

GSK Cervarix could save 'millions of women's lives throughout the world,' GSK exec says. Drug giant is seeking FDA approval in U.S.

Updated June 6, 2009

Premium Lock New study backs diabetes drug Avandia, GSK says

GSK Drug giant releases results of its own study at diabetes conferencing that it says downplays heart attack risks. WHO, meanwhile, endorses GSK diarrhea drug.

Updated June 3, 2009

Premium Lock FTC clears GSK's $3B buyout of Stiefel Labs

GSK growing larger Federal regulators on Tuesday cleared British drugmaker GlaxoSmithKline's $3 billion takeover of U.S. dermatology business Stiefel Laboratories Inc.

Updated May 22, 2009

Premium Lock Triangle region beat 100,000 new jobs goal, partnership says; more coming?

Charles Hayes Looking ahead, leaders of 13-county Research Triangle Regional Partnership outline new five-year plan for "Staying on Top." Recruiting pipeline is strong, RTRP’s top exec says. Since 2003, employment grew in all the region’s 13 counties but Warren, which lost 407 jobs.

Tags: IBM, Merck
Updated May 21, 2009

Premium Lock Want some good news? New report rates Triangle fifth among 11 top metros for biotech

Triangle ranks 5th in new Milken Institute study Milken Institute ranks RTP second for innovation as well as research and development. However, lack of 'risk capital' and entrepreneurship helps drag down its overall score.

Tags: GSK, Merck
Updated April 22, 2009

Premium Lock After profit drops, GSK CEO says U.S. operations face more changes

GSK 'It is essential that we reconfigure our U.S. business to make sure we have the right resource in the right areas and an overall lower level of infrastructure costs,' Andrew Witty says.

Updated April 17, 2009

Premium Lock New giant with Triangle roots to combat HIV - GSK, Pfizer form joint venture

Dominique Limet As yet unnamed company will based U.S. operations in RTP where GSK has a long history of AIDS research. Venture will be No. 2 in HIV drug market share from launch.

Updated March 18, 2009

Premium Lock NCRC: Merck vice president to head Murdock Research Institute

 North Carolina native to help coordinate research efforts at N.C. Research Institute.

Updated October 17, 2008

Premium Lock North Carolina unemployment hits 7 percent

Unemployment Despite an increase of more than 6,000 jobs, the state’s jobless rate has hit its highest level in six years.

Tags: Merck
September 3, 2008

Premium Lock Research Triangle Region posts $1 billion summer

RTRP New and expanding companies announced more than $1 billion in investments in the 13-county region from June through August for projects estimated to create nearly 1,700 new jobs, according to a new report released by the Research Triangle Regional Partnership (RTRP).

Updated July 28, 2008

Premium Lock Durham votes $2 million Merck incentives

 The Durham County Board of Commissioners voted unanimously Monday night to offer Merck, one of the world's largest pharmaceutical companies, a $2 million development incentive to expand its Treyburn Corporate Park facility.

July 21, 2008

Premium Lock A Lab, a Grant & a bad odor

Golden LEAF The decision of the Golden LEAF Foundation to spend $262,248 in public funds to promote the biodefense project and respond to its critics smells.

July 1, 2008

Premium Lock Durham-based drug startup lands $25M in new financing

 Papas Ventures, which launched CoLucid in 2005, participates in new round. CoLucid has anti-migraine compound in development.

Updated June 19, 2008

Premium Lock Merck to expand its Durham drug plant again

 The $300 million investment will bring the number of employee at the Durham facility to approximately 400.

Updated April 16, 2008

Premium Lock Fighting AIDS: Leading HIV Researchers to Collaborate on Vaccine Development

AIDS research UniversityTech: Center for HIV/AIDS Vaccine Immunology at Duke, International AIDS Vaccine Initiative plan to "lay the groundwork for new vaccine approaches."

Techwire Inside Partners
The Skinny: A Blog by Rick Smith

OUR INSIDERS

Frank Vinluan
Life science
Vivek Wadhwa
Commentary
Dr. Mike Walden
Tech economy
Scroll